Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Pharma Industry News AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals… byPallavi MadhirajuMarch 19, 2024